![](/img/cover-not-exists.png)
Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-LouisJournal:
Clinical Pharmacokinetics
DOI:
10.1007/s40262-019-00851-4
Date:
December, 2019
File:
PDF, 591 KB
2019